rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2009-5-15
|
pubmed:abstractText |
The aim of this study was to determine the presence of high-risk HPV-16 in patients with HNSCC, assess the impact of HPV status on treatment response and survival in this select cohort treated with combined modality therapy and to identify the differences in HIF-1alpha and VEGF expression in HPV-positive and -negative tumors.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0250-7005
|
pubmed:author |
pubmed-author:DickM FMF,
pubmed-author:EllenhornJoshuaJ,
pubmed-author:JOBJ CJC,
pubmed-author:JoSolomonS,
pubmed-author:JuhaszAgnesA,
pubmed-author:LiuXiyongX,
pubmed-author:LoeraSofiaS,
pubmed-author:PazBenjaminB,
pubmed-author:RuelChristopherC,
pubmed-author:ShibataStephenS,
pubmed-author:SomloGeorgeG,
pubmed-author:VoraNayanaN,
pubmed-author:WilczynskiSharon PSP,
pubmed-author:ZhangKeqiangK
|
pubmed:issnType |
Print
|
pubmed:volume |
29
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1467-74
|
pubmed:meshHeading |
pubmed-meshheading:19443352-Base Sequence,
pubmed-meshheading:19443352-Carcinoma, Squamous Cell,
pubmed-meshheading:19443352-Combined Modality Therapy,
pubmed-meshheading:19443352-DNA Primers,
pubmed-meshheading:19443352-Female,
pubmed-meshheading:19443352-Human papillomavirus 16,
pubmed-meshheading:19443352-Humans,
pubmed-meshheading:19443352-Male,
pubmed-meshheading:19443352-Middle Aged,
pubmed-meshheading:19443352-Oropharyngeal Neoplasms,
pubmed-meshheading:19443352-Prospective Studies,
pubmed-meshheading:19443352-Survival Analysis
|
pubmed:year |
2009
|
pubmed:articleTitle |
Human papillomavirus infection as a prognostic factor in oropharyngeal squamous cell carcinomas treated in a prospective phase II clinical trial.
|
pubmed:affiliation |
City of Hope National Medical Center, 1500 East Duarte Rd, Duarte, CA 91010, U.S.A.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase II,
Research Support, N.I.H., Extramural
|